Presbyopia is a ubiquitous and progressive symptom of aging that was previously only treatable with reading glasses, contacts or surgery, but patients now have a new option to help their aging eyes: eye drops.
The FDA approval of Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%, Allergan) in 2021 marked a paradigm shift in presbyopia treatment with a new noninvasive approach.
“There is a large number of presbyopes in the U.S., maybe close to 120 million,” Jay S. Pepose, MD, PhD, founder and medical director of Pepose Vision Institute in St. Louis, said. “To have a